Nest And Care Strengthens Its Commitment to Exceptional Senior Home Care in Bethesda, MD
Bethesda, MD - Nest And Care, a trusted leader in senior home care, reaffirms its dedication to providing exceptional in-home care services in Bethesda, MD. Under the leadership of Kat Villanueva, the company continues to set the gold standard for compassionate, personalized care, offering seniors the support they need to age comfortably at home while giving families peace of mind.
As the need for high-quality senior care grows, Nest And Care remains committed to helping families navigate the challenges of aging with dignity and confidence. The company's team of highly trained caregivers delivers tailored care solutions designed to meet each client's unique needs, ensuring seniors can thrive in the safety and familiarity of their own homes.
'At Nest And Care, we recognize that choosing care for a loved one is one of life's most important decisions,' said Kat Villanueva, Founder and CEO. 'Our mission is to go beyond basic care—to provide companionship, support, and a sense of security that allows seniors and their families to feel truly at ease.'
The company offers a comprehensive range of services, including assistance with daily activities, medication management, meal preparation, transportation, and specialized care for conditions such as dementia and Alzheimer's. Through individualized care plans, Nest And Care ensures that every senior receives the personalized attention they need to maintain their independence and quality of life.
For families in Bethesda seeking a reliable and compassionate senior care provider, Nest And Care continues to be the trusted choice. With a reputation built on excellence, professionalism, and genuine care, the company remains a pillar of support for the community.
For more information about Nest And Care and its senior home care services in Bethesda, MD, visit https://nestandcare.com.
Media Contact
Company Name: Nest And Care
Contact Person: Kat Villanueva
Email: Send Email
Phone: +1 213 448 9798
Address: 10411 Motor City Dr Suite 325
City: Bethesda
State: Maryland 20817
Country: United States
Website: https://nestandcare.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
2 hours ago
- Globe and Mail
Why Novo Nordisk Stock Bumped Higher on Friday
Key Points The Federal government might boost its support of weight-loss drugs soon. According to a media report, it's contemplating a five-year, experimental program that would subsidize their costs for qualifying patients. 10 stocks we like better than Novo Nordisk › Unexpected news of a potential support program from the federal government boosted the share prices of weight-loss drug developers on Friday. The poster boy for that still rather small group, Wegovy/Ozempic maker Novo Nordisk (NYSE: NVO), understandably saw a stock price lift that day. It rose by more than 2%, contrasting well with the 1.6% slide of the S&P 500 index. Federal help for obesity drugs? That news came from The Washington Post, which published an article stating that the Trump administration is planning an experimental program that would cover the costs of such medications. Citing documents from the Centers for Medicare and Medicaid Services (CMS) it had obtained, the newspaper said the plan would be implemented by state Medicaid administrations. It would also be utilized by Medicare Part D insurance plans. These entities would be allowed to cover weight-loss drugs for qualifying patients. At the moment, Medicare generally covers such treatments for patients who suffer from type 2 diabetes. Both Novo Nordisk's Wegovy and rival Eli Lilly 's Zepbound are essentially versions of predecessor diabetes drugs. Some private insurance plans cover obesity medications. The Post wrote that the experimental program will last for five years. Massive potential impact Novo Nordisk hasn't yet commented on the article, but we can be sure the company is excited about the prospect. Combined, Medicare and Medicaid are immense programs. Even if only a few states are willing to cover weight-loss treatments through them, the company could experience a surge in sales. For the stock's investors, this is a potentially very impactful development well worth monitoring. Should you invest $1,000 in Novo Nordisk right now? Before you buy stock in Novo Nordisk, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Novo Nordisk wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $625,254!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,090,257!* Now, it's worth noting Stock Advisor's total average return is 1,036% — a market-crushing outperformance compared to 181% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 29, 2025
CTV News
3 hours ago
- CTV News
Liberal U.S. states sue Trump over transgender care ban
The Pride flag seen at Windsor, Ont. on Aug. 1, 2025. (Gary Archibald/CTV News Windsor) A coalition of liberal U.S. states on Friday said it was suing U.S. President Donald Trump's administration over an order to prevent clinics providing gender-affirming care to children. The lawsuit, brought by officials from California and 15 other states, as well as the District of Columbia, challenges an executive order that denounces the treatment as 'chemical and surgical mutilation.' The order, which Trump signed in January, calls on the U.S. Department of Justice (DoJ) to investigate providers who offer such treatment, even in states where it is legal. 'The President and his Administration's relentless attacks on gender-affirming care endanger already vulnerable adolescents whose health and well-being are at risk,' California's Attorney General Rob Bonta said. 'Their demands that our healthcare providers discriminate against transgender individuals and deny them access to medically-necessary healthcare is cruel and irresponsible.' The DoJ said last month it had issued more than 20 subpoenas to doctors and clinics providing treatment to adolescents. U.S. Attorney General Pam Bondi said at the time that 'medical professionals and organizations that mutilated children in the service of a warped ideology will be held accountable.' The lawsuit, filed in a U.S. District Court in Massachusetts, argues that the administration's actions have no legal basis and should be declared unlawful. 'These actions have created a chilling effect in which providers are pressured to scale back on their care for fear of prosecution, leaving countless individuals without the critical care they need and are entitled to under law,' said Bonta. LGBTQ+ rights have become a divisive subject in the United States, where Trump rode a wave of public support for his crusade against so-called 'woke ideology.' In his first days in office, Trump declared the federal government would recognize only two genders -- men and women -- and has targeted transgender people in a slew of other orders. In February, he issued an executive order aimed at banning transgender athletes, allowing federal agencies to halt funding to any institution that does not consider birth-assigned genders in determining sex. The lawsuit groups California with New York, Massachusetts, Illinois, Connecticut, Delaware, Hawaii, Maine, Maryland, Michigan, Nevada, New Jersey, New Mexico, Rhode Island, Wisconsin, Pennsylvania and the District of Columbia. It is the latest legal effort from a coalition of Democratic-run states aimed at pushing back at what liberals see as overreach by the Trump presidency.
Globe and Mail
5 hours ago
- Globe and Mail
Shaping the Future of Medicine: Dr. Guy Navarra Launches Scholarship for Aspiring Physicians
Shaping the Future of Medicine: Dr. Guy Navarra Launches Scholarship for Aspiring Physicians Newburyport, Massachusetts - Undergraduate students with dreams of becoming doctors now have a new opportunity to jumpstart their journey, thanks to the launch of the Dr. Guy Navarra Scholarship for Future Doctors. This $1,000 scholarship recognizes and supports one outstanding student preparing to enter the medical field—someone whose vision, heart, and dedication echo the values of its founder, Dr. Guy Navarra. The scholarship, now accepting applications, is designed for U.S.-based undergraduate students pursuing careers in medicine, pre-medical studies, or related health sciences. With the growing need for committed, forward-thinking professionals in healthcare, Dr. Guy Navarra aims to reward a student who not only excels academically but also holds a strong purpose for making an impact in tomorrow's healthcare system. To apply, students must submit a personal essay (500–800 words) in response to the following prompt: 'What inspires your journey into medicine, and how do you envision making a meaningful impact on the healthcare system of tomorrow?' Essays will be judged on clarity, authenticity, creativity, and alignment with the mission of Dr. Navarra's scholarship: to cultivate leadership, empathy, and transformation in the next generation of doctors. Dr. Guy Navarra brings a wealth of knowledge and inspiration to this initiative. With over 25 years of experience in internal medicine, geriatrics, and obesity medicine, he has held roles in clinical care, academic research, hospital leadership, and executive strategy. A graduate of Madrid's Complutense University, and later Yale and Harvard, Dr. Guy Navarra exemplifies what it means to blend global education with patient-centered care. His commitment to preventative medicine and ethical innovation has shaped programs, improved lives, and helped bridge gaps in the healthcare system. Currently serving as primary care physician for the Greater Newburyport area and Chief Medical Officer for MetTrimMD, Dr. Guy Navarra continues to lead by example—pioneering patient-first approaches to metabolic health and chronic disease management. Through this scholarship, he now turns his focus to supporting students who are following in his footsteps. 'The future of medicine depends not just on knowledge, but on heart and vision,' says Dr. Guy Navarra. 'This scholarship is a way to honor students who are already showing signs of leadership, passion, and the ability to think critically about where healthcare is headed.' Interested students should email their essay submission along with basic academic details—name, major, university, expected graduation year, and a short bio—to apply@ The deadline to apply is April 15, 2026, and the scholarship recipient will be publicly announced on May 15, 2026. The $1,000 award can be applied toward tuition, educational supplies, or other school-related expenses. It's not just a financial boost—it's a mark of recognition from a physician who believes deeply in mentoring the leaders of tomorrow. To learn more, visit the official scholarship site at Media Contact Company Name: Dr. Guy Navarra Scholarship Contact Person: Dr. Guy Navarra Email: Send Email City: Newburyport State: Massachusetts Country: United States Website:
